Deborah W. Brooks, co-founder and executive vice chairman of the Michael J. Fox Foundation for Parkinson’s Research, says there’s more promise in the medical pipeline today for people with Parkinson’s disease than in the past.

That progress is driven by people who participate in clinical trials and other studies.

Brooks plans to speak about the roles patients and families can play in speeding treatment advances during the Parkinson’s disease symposium, to be held from 5:30-7 p.m., Wednesday, Aug. 19, at the Health Sciences Complex on the University of Delaware’s Science, Technology and Advanced Research (STAR) Campus.

“Much of what we see moving into the clinical stage of testing are really novel approaches. These are things that go beyond the current arsenal of dopamine-based treatments,” said Brooks, who lives in Delaware and served as president and chief executive officer of the Fox Foundation from October 2000 to February 2007. “The pipeline for drug development is as good as it’s been for decades.” Read more

Skip to content